| 1 | E2F1, NOVA2, PPARG
|
| Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells.
|
| Belloni E, Di Matteo A, Pradella D, Vacca M, Wyatt CDR, Alfieri R, Maffia A, Sabbioneda S, Ghigna C.
|
| Cell Nov 23;8(12):1498. doi: 10.3390/cells8121498 2019
|
| 2 | FGF11, PPARG
|
| FGF11 influences 3T3-L1 preadipocyte differentiation by modulating the expression of PPARγ regulators.
|
| Lee KW, Jeong JY, An YJ, Lee JH, Yim HS.
|
| FEBS Open Bio. Mar 12;9(4):769-780. doi: 10.1002/2211-5463.12619. 2019
|
| 3 | MAGED1, PPARG
|
| Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1.
|
| Wang Q, Tang J, Jiang S, Huang Z, Song A, Hou S, Gao X, Ruan HB.
|
| J Endocrinol Endocrinol. 2018 Aug 18. pii: JOE-18-0349. doi: 10.1530/JOE-18-0349. [Epub ahead of print]
2018
|
| 4 | PIAS1, PPARG
|
| PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
|
| Xie B, Liu X, Yang J, Cheng J, Gu J, Xue S.
|
| BMC Cell Biol 19(1):24. doi: 10.1186/s12860-018-0176-x.
2018
|
| 5 | DLC1, PPARG
|
| Regulation of white and brown adipocyte differentiation by RhoGAP DLC1.
|
| Sim CK, Kim SY, Brunmeir R, Zhang Q, Li H, Dharmasegaran D, Leong C, Lim YY, Han W, Xu F.
|
| PLoS One 12(3):e0174761. doi: 10.1371/journal.pone.0174761. eCollection 2017.
2017
|
| 6 | CACUL1, KDM1A, PPARG, SIRT1
|
| CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis.
|
| Jang MJ, Park UH, Kim JW, Choi H, Um SJ, Kim EJ.
|
| Cell Death Dis 8(12):3201. doi: 10.1038/s41419-017-0070-z.
2017
|
| 7 | PPARG, ZFP36L1
|
| Zinc finger protein ZFP36L1 promotes osteoblastic differentiation but represses adipogenic differentiation of mouse multipotent cells.
|
| Tseng KY, Chen YH, Lin S.
|
| Oncotarget Mar 28;8(13):20588-20601. doi: 10.18632/oncotarget.15246 2017
|
| 8 | HES6, PPARG
|
| Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of Pparg2 expression. 2017 PMID:
|
| Park JE, Lee M, Kim SC, Zhang Y, Hardwick JP, Lee YK.
|
| Hepatol Commun. Nov 8;1(10):1085-1098. doi: 10.1002/hep4.1120. 2017
|
| 9 | AJUBA, CREBBP, PPARG
|
| The LIM protein Ajuba promotes adipogenesis by enhancing PPARγ and p300/CBP interaction.
|
| Li Q, Peng H, Fan H, Zou X, Liu Q, Zhang Y, Xu H, Chu Y, Wang C, Ayyanathan K, Rauscher FJ, Zhang K, Hou Z.
|
| Cell Death Differ 23(1):158-68. doi: 10.1038/cdd.2015.83.
2016
|
| 10 | CEBPA, MEST, PPARG, SOX6
|
| The transcription factor SOX6 contributes to the developmental origins of obesity by promoting adipogenesis.
|
| Leow SC, Poschmann J, Too PG, Yin J, Joseph R, McFarlane C, Dogra S, Shabbir A, Ingham PW, Prabhakar S, Leow MK, Lee YS, Ng KL, Chong YS, Gluckman PD, Stünkel W.
|
| Development Mar 15;143(6):950-61. doi: 10.1242/dev.131573. Epub 2016 Feb 18 2016
|
| 11 | ATF3, PPARG
|
| ATF3 inhibits PPARγ-stimulated transactivation in adipocyte cells.
|
| Jang MK, Jung MH.
|
| Biochem Biophys Res Commun 456(1):80-5. doi: 10.1016/j.bbrc.2014.11.037. Epub 2014 Nov 21.
2015
|
| 12 | FLII, PPARG
|
| Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.
|
| Choi JS, Choi SS, Kim ES, Seo YK, Seo JK, Kim EK, Suh PG, Choi JH.
|
| Cell Signal 27(3):614-20. doi: 10.1016/j.cellsig.2014.11.035. Epub 2014 Dec 2.
2015
|
| 13 | CD36, PPARG, TCF4, WNT1
|
| Wnt1 positively regulates CD36 expression via TCF4 and PPAR-γ in macrophages.
|
| Wang S, Sun Z, Zhang X, Li Z, Wu M, Zhao W, Wang H, Chen T, Yan H, Zhu J.
|
| Cell Physiol Biochem 35(4):1289-302. doi: 10.1159/000373951.
2015
|
| 14 | PPARG, TRIM23
|
| The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ.
|
| Watanabe M, Takahashi H, Saeki Y, Ozaki T, Itoh S, Suzuki M, Mizushima W, Tanaka K, Hatakeyama S.
|
| Elife 4:e05615. doi: 10.7554/eLife.05615.
2015
|
| 15 | CEBPA, CEBPB, CEBPD, JMJD6, PPARG
|
| Transcriptional and post-transcriptional control of adipocyte differentiation by Jumonji domain-containing protein 6.
|
| Hu YJ, Belaghzal H, Hsiao WY, Qi J, Bradner JE, Guertin DA, Sif S, Imbalzano AN.
|
| Nucleic Acids Res 43(16):7790-804. doi: 10.1093/nar/gkv645. Epub 2015 Jun 27.
2015
|
| 16 | ADTRP, PPARG
|
| The coronary artery disease-associated gene C6ORF105 is expressed in human macrophages under the transcriptional control of PPARγ.
|
| Chinetti-Gbaguidi G, Copin C, Derudas B, Vanhoutte J, Zawadzki C, Jude B, Haulon S, Pattou F, Marx N, Staels B.
|
| FEBS Lett 589(4):461-6. doi: 10.1016/j.febslet.2015.01.002. Epub 2015 Jan 14.
2015
|
| 17 | PPARG, SEPTIN2
|
| Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
|
| Cao LQ, Shao ZL, Liang HH, Zhang DW, Yang XW, Jiang XF, Xue P.
|
| Cancer Lett 359(1):127-35. doi: 10.1016/j.canlet.2015.01.004. Epub 2015 Jan 12.
2015
|
| 18 | MRTFA, PPARG
|
| Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation.
|
| Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y, Chiyoda T, Akashi K, Saya H, Kano K.
|
| Nat Commun 5:3368. doi: 10.1038/ncomms4368. 2014
|
| 19 | ATF3, PPARG
|
| ATF3 represses PPARγ expression and inhibits adipocyte differentiation.
|
| Jang MK, Jung MH.
|
| Biochem Biophys Res Commun 454(1):58-64. doi: 10.1016/j.bbrc.2014.10.028. Epub 2014 Oct 14.
2014
|
| 20 | FABP4, PPARG
|
| FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues.
|
| Garin-Shkolnik T, Rudich A, Hotamisligil GS, Rubinstein M.
|
| Diabetes 63(3):900-11. doi: 10.2337/db13-0436. Epub 2013 Dec 6.
2014
|
| 21 | GATA2, PPARG
|
| GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation.
|
| Zhou Q, Guan W, Qiao H, Cheng Y, Li Z, Zhai X, Zhou Y.
|
| Biochim Biophys Acta 1842(12 Pt A):2367-77. doi: 10.1016/j.bbadis.2014.10.001.
2014
|
| 22 | CSF2, PPARG
|
| Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages.
|
| Schneider C, Nobs SP, Kurrer M, Rehrauer H, Thiele C, Kopf M.
|
| Nat Immunol 15(11):1026-37. doi: 10.1038/ni.3005. Epub 2014 Sep 28.
2014
|
| 23 | PPARG, VIM
|
| Cytoskeletal protein vimentin interacts with and regulates peroxisome proliferator-activated receptor gamma via a proteasomal degradation process.
|
| Tsai YC, Tsai SH, Chang EY, Hee SW, Chen WH, Lee SC, Chuang LM.
|
| J Cell Biochem Cell Biochem. 2013 Jan 7. doi: 10.1002/jcb.24497. [Epub ahead of print]
2013
|
| 24 | MAFA, PDX1, PPARG
|
| PPARγ activation attenuates glycated-serum induced pancreatic beta-cell dysfunction through enhancing Pdx1 and Mafa protein stability.
|
| Zhu Y, Ma A, Zhang H, Li C.
|
| PLoS One 8(2):e56386. doi: 10.1371/journal.pone.0056386. Epub 2013 Feb 12.
2013
|
| 25 | PPARG, TAF7L
|
| Dual functions of TAF7L in adipocyte differentiation.
|
| Zhou H, Kaplan T, Li Y, Grubisic I, Zhang Z, Wang PJ, Eisen MB, Tjian R.
|
| Elife 2:e00170. doi: 10.7554/eLife.00170.
2013
|
| 26 | MUC1, PPARG
|
| PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability.
|
| Hou Y, Gao J, Xu H, Xu Y, Zhang Z, Xu Q, Zhang C.
|
| Oncogene ncogene. 2013 Dec 2. doi: 10.1038/onc.2013.504. [Epub ahead of print]
2013
|
| 27 | LIPE, MC2R, MRAP, PPARG
|
| Transcriptional activation of melanocortin 2 receptor accessory protein by PPARγ in adipocytes.
|
| Kim NS, Kim YJ, Cho SY, Lee TR, Kim SH.
|
| Biochem Biophys Res Commun 439(3):401-6. doi: 10.1016/j.bbrc.2013.08.061. Epub 2013 Aug 28.
2013
|
| 28 | PPARG, PTGES
|
| Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes.
|
| García-Alonso V, López-Vicario C, Titos E, Morán-Salvador E, González-Périz A, Rius B, Párrizas M, Werz O, Arroyo V, Clŕria J.
|
| J Biol Chem 288(39):28230-42. doi: 10.1074/jbc.M113.468603. Epub 2013 Aug 13.
2013
|
| 29 | GPS2, NCOR2, PPARG, TWIST1
|
| SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation.
|
| Toubal A, Clément K, Fan R, Ancel P, Pelloux V, Rouault C, Veyrie N, Hartemann A, Treuter E, Venteclef N.
|
| J Clin Invest 123(1):362-79. doi: 10.1172/JCI64052. Epub 2012 Dec 10.
2013
|
| 30 | FAM57B, PPARG
|
| Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis.
|
| Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Kanesaki-Yatsuka Y, Matsumoto M, Mizuno Y, Okazaki Y.
|
| J Biol Chem 288(7):4522-37. doi: 10.1074/jbc.M112.440792. Epub 2012 Dec 28.
2013
|
| 31 | LPIN1, PPARG
|
| Lipin1 regulates PPARγ transcriptional activity.
|
| Kim HE, Bae E, Jeong DY, Kim MJ, Jin WJ, Park SW, Han GS, Carman GM, Koh E, Kim KS.
|
| Biochem J 453(1):49-60. doi: 10.1042/BJ20121598.
2013
|
| 32 | FAM3A, PPARG
|
| FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.
|
| Zhou Y, Jia S, Wang C, Chen Z, Chi Y, Li J, Xu G, Guan Y, Yang J.
|
| Biochim Biophys Acta 1830(8):4160-70. doi: 10.1016/j.bbagen.2013.03.029. Epub 2013 Apr 3.
2013
|
| 33 | PPARG, SIAH2
|
| The ubiquitin ligase Siah2 regulates PPARγ activity in adipocytes.
|
| Kilroy G, Kirk-Ballard H, Carter LE, Floyd ZE.
|
| Endocrinology 153(3):1206-18. Epub 2012 Jan 31.
2012
|
| 34 | LPIN1, PPARG
|
| Lipin-1 phosphatidic phosphatase activity modulates phosphatidate levels to promote peroxisome proliferator-activated receptor γ (PPARγ) gene expression during adipogenesis.
|
| Zhang P, Takeuchi K, Csaki LS, Reue K.
|
| J Biol Chem 287(5):3485-94. doi: 10.1074/jbc.M111.296681. Epub 2011 Dec 6.
2012
|
| 35 | PPARG, RXRA
|
| Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
|
| Ruebner M, Langbein M, Strissel PL, Henke C, Schmidt D, Goecke TW, Faschingbauer F, Schild RL, Beckmann MW, Strick R.
|
| J Cell Biochem 113(7):2383-96. doi: 10.1002/jcb.24110.
2012
|
| 36 | MUC1, PPARG
|
| PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism.
|
| Park YS, Lillehoj EP, Kato K, Park CS, Kim KC.
|
| Am J Physiol Lung Cell Mol Physiol 302(7):L679-87. doi: 10.1152/ajplung.00360.2011. Epub 2012 Jan 20.
2012
|
| 37 | CEBPA, DICER1, PPARG
|
| Dicer has a crucial role in the early stage of adipocyte differentiation, but not in lipid synthesis, in 3T3-L1 cells.
|
| Fujimoto Y, Nakagawa Y, Shingyouchi A, Tokushige N, Nakanishi N, Satoh A, Matsuzaka T, Ishii KA, Iwasaki H, Kobayashi K, Yatoh S, Suzuki H, Yahagi N, Urayama O, Yamada N, Shimano H.
|
| Biochem Biophys Res Commun 420(4):931-6. doi: 10.1016/j.bbrc.2012.03.110. Epub 2012 Mar 26.
2012
|
| 38 | PPARG, SAV1, STK3, STK4
|
| Mammalian ste20-like kinase and SAV1 promote 3T3-L1 adipocyte differentiation by activation of PPARγ.
|
| Park BH, Kim DS, Won GW, Jeon HJ, Oh BC, Lee Y, Kim EG, Lee YH.
|
| PLoS One 7(1):e30983. doi: 10.1371/journal.pone.0030983. Epub 2012 Jan 26.
2012
|
| 39 | MGAT1, PPARG
|
| Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis.
|
| Lee YJ, Ko EH, Kim JE, Kim E, Lee H, Choi H, Yu JH, Kim HJ, Seong JK, Kim KS, Kim JW.
|
| Proc Natl Acad Sci U S A 109(34):13656-61. doi: 10.1073/pnas.1203218109. Epub 2012 Aug 6.
2012
|
| 40 | PPARG, REST, TBX20
|
| Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function.
|
| Sakabe NJ, Aneas I, Shen T, Shokri L, Park SY, Bulyk ML, Evans SM, Nobrega MA.
|
| Hum Mol Genet 21(10):2194-204. doi: 10.1093/hmg/dds034. Epub 2012 Feb 10.
2012
|
| 41 | HR, PPARG
|
| Hairless promotes PPARγ expression and is required for white adipogenesis.
|
| Kumpf S, Mihlan M, Goginashvili A, Grandl G, Gehart H, Godel A, Schmidt J, Müller J, Bezzi M, Ittner A, Guccione E, Wolfrum C, Ricci R.
|
| EMBO Rep 13(11):1012-20. doi: 10.1038/embor.2012.133. Epub 2012 Sep 11.
2012
|
| 42 | FGF1, PPARG
|
| A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis.
|
| Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, Yu RT, Olefsky JM, Henry RR, Downes M, Evans RM.
|
| Nature 485(7398):391-4. doi: 10.1038/nature10998.
2012
|
| 43 | BHLHE40, PPARG
|
| Differentiated embryo chondrocyte 1 (DEC1) represses PPARγ2 gene through interacting with CCAAT/enhancer binding protein β (C/EBPβ).
|
| Park YK, Park H.
|
| Mol Cells 33(6):575-81. doi: 10.1007/s10059-012-0002-9. Epub 2012 May 18.
2012
|
| 44 | PPARG
|
| Peroxisome proliferator-activated receptor γ is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress.
|
| Yang Y, Qin X, Liu S, Li J, Zhu X, Gao T, Wang X.
|
| J Neurochem. 118(3):429-39. 2011
|
| 45 | PPARG
|
| Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
|
| Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G, Nalbandian S, Fan W, Gayen JR, Mahata SK, Webster NJ, Schwartz MW, Olefsky JM.
|
| Nat Med. 17(5):618-22. 2011
|
| 46 | PPARG
|
| A role for central nervous system PPAR-γ in the regulation of energy balance.
|
| Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ.
|
| Nat Med. 17(5):623-6. 2011
|
| 47 | PPARG, SERPINF1, TNFSF10
|
| Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
|
| Ho TC, Chen SL, Shih SC, Chang SJ, Yang SL, Hsieh JW, Cheng HC, Chen LJ, Tsao YP.
|
| J Biol Chem 286(41):35943-54. doi: 10.1074/jbc.M111.266064. Epub 2011 Aug 16.
2011
|
| 48 | FTO, HMGA2, HNF1A, IRS1, KCNJ11, KCNQ1, KLF14, PPARG
|
| Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.
|
| Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrč AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Bengtsson Boström K, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Couper DJ, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jřrgensen T, Kao WH, Klopp N, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Perry JR, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsř T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Mohlke KL, Morris AD, Palmer CN, Pramstaller PP, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS, Pedersen O, Wichmann HE, Barroso I, Florez JC, Frayling TM, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI; MAGIC investigators; GIANT Consortium.
|
| Nat Genet 42(7):579-89.PMID: 20581827 2010
|
| 49 | APMAP, PPARG
|
| Reconstruction of gene association network reveals a transmembrane protein required for adipogenesis and targeted by PPARγ.
|
| Bogner-Strauss JG, Prokesch A, Sanchez-Cabo F, Rieder D, Hackl H, Duszka K, Krogsdam A, Di Camillo B, Walenta E, Klatzer A, Lass A, Pinent M, Wong WC, Eisenhaber F, Trajanoski Z.
|
| Cell Mol Life Sci 67(23):4049-64. Epub 2010 Jun 15.
2010
|
| 50 | PPARG
|
| Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma).
|
| Singh AK, Battu A, Mohareer K, Hasnain SE, Ehtesham NZ.
|
| PLoS One. 5(3):e9912. 2010
|
| 51 | PPARG, TRH
|
| Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo.
|
| Kouidhi S, Seugnet I, Decherf S, Guissouma H, Elgaaied AB, Demeneix B, Clerget-Froidevaux MS.
|
| Mol Cell Endocrinol 317(1-2):44-52. doi: 10.1016/j.mce.2009.11.001. Epub 2009 Nov 10.
2010
|
| 52 | AACS, PPARG
|
| Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma.
|
| Aguiló F, Camarero N, Relat J, Marrero PF, Haro D.
|
| Biochem J 427(2):255-64. doi: 10.1042/BJ20090851.
2010
|
| 53 | AEBP1, NR1H3, PPARG
|
| PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.
|
| Majdalawieh A, Ro HS.
|
| Nucl Recept Signal 8:e004. doi: 10.1621/nrs.08004. Review.
2010
|
| 54 | MED14, PPARG
|
| MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis.
|
| Grřntved L, Madsen MS, Boergesen M, Roeder RG, Mandrup S.
|
| Mol Cell Biol. May;30(9):2155-69. doi: 10.1128/MCB.01238-09. Epub 2010 Mar 1 2010
|
| 55 | PPARG, SRSF1
|
| Splicing factor ASF/SF2 and transcription factor PPAR-gamma cooperate to directly regulate transcription of uncoupling protein-3.
|
| Kim DJ, Oh B, Kim YY.
|
| Biochem Biophys Res Commun 378(4):877-82. Epub 2008 Dec 13. 2009
|
| 56 | CDX1, CEBPA, PPARG
|
| Homeodomain transcription factor CDX1 is required for the transcriptional induction of PPARgamma in intestinal cell differentiation.
|
| Park MJ, Kim HY, Kim K, Cheong J.
|
| FEBS Lett 583(1):29-35. Epub 2008 Dec 4.
2009
|
| 57 | MEN1, PPARG
|
| The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
|
| Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Höppener JW, Lips CJ, Kummer JA, Kalkhoven E, Timmers HT.
|
| Mol Cell Biol 29(18):5060-9. Epub 2009 Jul 13.
2009
|
| 58 | PPARG
|
| Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis.
|
| Takada I, Kouzmenko AP, Kato S.
|
| Nat Rev Rheumatol 5(8):442-7. Epub 2009 Jul 7. Review.PMID: 19581903 2009
|
| 59 | PPARG
|
| The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.
|
| Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Beyer M, Mayer G, Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts C, Knolle PA.
|
| J Exp Med 206(10):2079-89. Epub 2009 Sep 8. Erratum in: J Exp Med. 2009 Dec 21;206(13):3159. Novak, Natalija [corrected to Nowak, Nina]. P 2009
|
| 60 | IDE, PPARG
|
| PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
|
| Du J, Zhang L, Liu S, Zhang C, Huang X, Li J, Zhao N, Wang Z.
|
| Biochem Biophys Res Commun 383(4):485-90. Epub 2009 Apr 19.PMID: 19383491 2009
|
| 61 | PPARG
|
| Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage.
|
| Toth B, Bastug M, Mylonas I, Scholz C, Makovitzky J, Kunze S, Thaler C, Friese K, Jeschke U.
|
| Acta Histochem 111(4):372-8. Epub 2009 Apr 1.PMID: 19342081 2009
|
| 62 | NR0B1, PPARG
|
| The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma.
|
| Kim GS, Lee GY, Nedumaran B, Park YY, Kim KT, Park SC, Lee YC, Kim JB, Choi HS.
|
| Biochem Biophys Res Commun 370(2):264-8. Epub 2008 Mar 31.
2008
|
| 63 | FGF21, PPARG
|
| Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes.
|
| Wang H, Qiang L, Farmer SR.
|
| Mol Cell Biol 28(1):188-200. Epub 2007 Oct 22.PMID: 17954559 2008
|
| 64 | MED1, PPARG
|
| Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression.
|
| Ge K, Cho YW, Guo H, Hong TB, Guermah M, Ito M, Yu H, Kalkum M, Roeder RG.
|
| Mol Cell Biol 28(3):1081-91. Epub 2007 Nov 26.PMID: 18039840 2008
|
| 65 | CXCR2, PPARG
|
| Induction of CXCR2 receptor by peroxisome proliferator-activated receptor gamma in human macrophages.
|
| Rigamonti E, Fontaine C, Lefebvre B, Duhem C, Lefebvre P, Marx N, Staels B, Chinetti-Gbaguidi G.
|
| Arterioscler Thromb Vasc Biol 28(5):932-9. Epub 2008 Feb 21.PMID: 18292390 2008
|
| 66 | PPARG
|
| The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.
|
| Costa V, Foti D, Paonessa F, Chiefari E, Palaia L, Brunetti G, Gulletta E, Fusco A, Brunetti A.
|
| Endocr Relat Cancer. 15(1):325-35. 2008
|
| 67 | PPARG
|
| The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma.
|
| van Beekum O, Brenkman AB, Grřntved L, Hamers N, van den Broek NJ, Berger R, Mandrup S, Kalkhoven E.
|
| Endocrinology. 149(4):1840-9. 2008
|
| 68 | PPARG
|
| Effects of the Type 2 Diabetes-Associated PPARG P12A Polymorphism on Progression to Diabetes and Response to Troglitazone.
|
| Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D.
|
| J Clin Endocrinol Metab 92(4):1502-9. Epub 2007 Jan 9. 2007
|
| 69 | PPARG, KCNJ11, TCF7L2, CDKAL1
|
| Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
|
| Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS; Wellcome Trust Case Control Consortium (WTCCC), Burton PR, Clayton DG, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Davison D, Easton D, Evans D, Leung HT, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskvina V, Nikolov I, O'donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop DT, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Mathew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop GM, Connell J, Dominiczak A, Braga Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfield M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hider SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DP, Thomson W, Worthington J, Dunger DB, Widmer B, Newport M, Sirugo G, Lyons E, Vannberg F, Hill AV, Bradbury LA, Farrar C, Pointon JJ, Wordsworth P, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Gough SC, Seal S, Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Rockett KA, Bumpstead SJ, Chaney A, Downes K, Ghori MJ, Gwilliam R, Hunt SE, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Widden C, Withers D, Cardin NJ, Ferreira T, Pereira-Gale J, Hallgrimsdottir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Compston A, Ouwehand NJ, Samani MR, Isaacs JD, Morgan AW, Wilson GD, Ardern-Jones A, Berg J, Brady A, Bradshaw N, Brewer C, Brice G, Bullman B, Campbell J, Castle B, Cetnarsryj R, Chapman C, Chu C, Coates N, Cole T, Davidson R, Donaldson A, Dorkins H, Douglas F, Eccles D, Eeles R, Elmslie F, Evans DG, Goff S, Goodman S, Goudie D, Gray J, Greenhalgh L, Gregory H, Hodgson SV, Homfray T, Houlston RS, Izatt L, Jackson L, Jeffers L, Johnson-Roffey V, Kavalier F, Kirk C, Lalloo F, Langman C, Locke I, Longmuir M, Mackay J, Magee A, Mansour S, Miedzybrodzka Z, Miller J, Morrison P, Murday V, Paterson J, Pichert G, Porteous M, Rahman N, Rogers M, Rowe S, Shanley S, Saggar A, Scott G, Side L, Snadden L, Steel M, Thomas M, Thomas S, McCarthy MI, Hattersley AT.
|
| Science 316(5829):1336-41. Epub 2007 Apr 26. 2007
|
| 70 | FPLD3,PPARG
|
| Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
|
| Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T.
|
| J Clin Endocrinol Metab 92(5):1606-12. Epub 2007 Feb 13. 2007
|
| 71 | PPARG
|
| A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation.
|
| Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S.
|
| Nat Cell Biol. 9(11):1273-85. 2007
|
| 72 | PPARG
|
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.
|
| Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A.
|
| Nature. 447(7148):1116-20. 2007
|
| 73 | PPARG
|
| PPAR-gamma regulates osteoclastogenesis in mice.
|
| Wan Y, Chong LW, Evans RM.
|
| Nat Med. 13(12):1496-503. 2007
|
| 74 | PPARG, FPLD3
|
| Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
|
| Francis GA, Li G, Casey R, Wang J, Cao H, Leff T, Hegele RA.
|
| BMC Med Genet 7:3. 2006
|
| 75 | PPARG
|
| Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.
|
| Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Imai J, Hasegawa Y, Gao J, Kaneko K, Iwasaki H, Ishihara H, Sasano H, Inukai K, Mizuguchi H, Asano T, Shiota M, Nakazato M, Oka Y.
|
| Science 312(5780):1656-9. 2006
|
| 76 | FPLD3, PPARG
|
| A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
|
| Hegele RA, Ur E, Ransom TP, Cao H.
|
| Clin Genet 70(4):360-2. No abstract available. 2006
|
| 77 | NCOA3, PPARG, CREBBP
|
| Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program.
|
| Louet JF, Coste A, Amazit L, Tannour-Louet M, Wu RC, Tsai SY, Tsai MJ, Auwerx J, O'Malley BW.
|
| Proc Natl Acad Sci U S A 103(47):17868-73. Epub 2006 Nov 10. 2006
|
| 78 | CYPHB1, CYPHB2, NR3C2, HSD11B2, SCNN1B, SCNN1G, PSALD, PHA2C, WNK1, PHA2B, WNK4, DIDAN, PPARG, MTHHH, MT-TI
|
| The genetic dissection of essential hypertension.
|
| Cowley AW Jr.
|
| Nat Rev Genet 7(11):829-40. Epub 2006 Oct 10. Review. 2006
|
| 79 | PAX8, PPARG
|
| PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth.
|
| Au AY, McBride C, Wilhelm KG Jr, Koenig RJ, Speller B, Cheung L, Messina M, Wentworth J, Tasevski V, Learoyd D, Robinson BG, Clifton-Bligh RJ.
|
| Endocrinology 147(1):367-76. Epub 2005 Sep 22. 2006
|
| 80 | PPARG
|
| Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
|
| Tomaru T, Satoh T, Yoshino S, Ishizuka T, Hashimoto K, Monden T, Yamada M, Mori M.
|
| Endocrinology. 147(1):377-88. 2006
|
| 81 | ADIPOQ, IRS1, PPARG
|
| Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men.
|
| Mousavinasab F, Tahtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, Keinanen-Kiukaanniemi S, Laakso M.
|
| Mol Genet Metab 84(4):344-8. Epub 2005 Jan 25. 2005
|
| 82 | PPARG
|
| A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.
|
| Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK.
|
| Nature 437(7059):759-63. Epub 2005 Aug 28. 2005
|
| 83 | CYP27A1, PPARG
|
| Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands.
|
| Quinn CM, Jessup W, Wong J, Kritharides L, Brown AJ.
|
| Biochem J 385(Pt 3):823-30. 2005
|
| 84 | PAX8, PPARG
|
| Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
|
| Lui WO, Foukakis T, Liden J, Thoppe SR, Dwight T, Hoog A, Zedenius J, Wallin G, Reimers M, Larsson C.
|
| Oncogene 24(8):1467-76. 2005
|
| 85 | CEP350, PPARG
|
| Activity and subcellular compartmentalization of peroxisome proliferator-activated receptor alpha are altered by the centrosome-associated protein CAP350.
|
| Patel H, Truant R, Rachubinski RA, Capone JP.
|
| J Cell Sci 118(Pt 1):175-86. 2005
|
| 86 | PPARG, KLF15
|
| Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis.
|
| Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, Nakamura K, Nakamura T, Yamauchi T, Kubota N, Kadowaki T, Matsuki Y, Ogawa W, Hiramatsu R, Kasuga M.
|
| J Biol Chem 280(13):12867-75. Epub 2005 Jan 20. 2005
|
| 87 | PPARG
|
| Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
|
| Zhang J, Fu M, Cui T, Xiong C, Xu K, Zhong W, Xiao Y, Floyd D, Liang J, Li E, Song Q, Chen YE.
|
| Proc Natl Acad Sci U S A 101(29):10703-8. Epub 2004 Jul 12. 2004
|
| 88 | PPARG
|
| Impact of genetic variation of PPARgamma in humans.
|
| Meirhaeghe A, Amouyel P.
|
| Mol Genet Metab 83(1-2):93-102. 2004
|
| 89 | PPARG
|
| PPARs and the complex journey to obesity.
|
| Evans RM, Barish GD, Wang YX.
|
| Nat Med. 10(4):355-61 2004
|
| 90 | PPARG
|
| Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
|
| Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N.
|
| J Clin Invest. 114(2):240-9. 2004
|
| 91 | PPARD, PPARG
|
| PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.
|
| Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK.
|
| Proc Natl Acad Sci U S A 100(11):6712-7. Epub 2003 May 09. 2003
|
| 92 | PPARG, RUNX2
|
| Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts.
|
| Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, Park SW, Kim SY, Shin CS.
|
| J Biol Chem 278(26):23270-7. Epub 2003 Apr 18. 2003
|
| 93 | PPARG
|
| The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
|
| Caramori ML, Canani LH, Costa LA, Gross JL.
|
| Diabetes 52(12):3010-3. 2003
|
| 94 | PPARG
|
| Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways.
|
| Dowell P, Otto TC, Adi S, Lane MD.
|
| J Biol Chem. 278(46):45485-91. 2003
|
| 95 | PPARG
|
| Genetic deficiency in Pparg does not alter development of experimental prostate cancer
|
| Saez E, Olson P, Evans RM.
|
| Nat Med. 9(10):1265-6 2003
|
| 96 | PPARG
|
| Muscle-specific Pparg deletion causes insulin resistance.
|
| Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J.
|
| Nat Med. 9(12):1491-7. 2003
|
| 97 | PPARG
|
| Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
|
| He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM.
|
| Proc Natl Acad Sci U S A. 100(26):15712-7. 2003
|
| 98 | PPARG
|
| Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.
|
| Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu CH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM.
|
| Mol Cell Biol. 23(20):7222-9. 2003
|
| 99 | FPLD3, PPARG
|
| PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.
|
| Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T.
|
| Diabetes 51(12):3586-90. 2002
|
| 100 | EDF1, PPARG
|
| Multiprotein bridging factor-1 (MBF-1) is a cofactor for nuclear receptors that regulate lipid metabolism.
|
| Brendel C, Gelman L, Auwerx J.
|
| Mol Endocrinol 16(6):1367-77. 2002
|
| 101 | PPARG, FPLD3
|
| A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
|
| Agarwal AK, Garg A.
|
| J Clin Endocrinol Metab 87(1):408-11. 2002
|
| 102 | PPARG
|
| Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation.
|
| Nishizawa H, Yamagata K, Shimomura I, Takahashi M, Kuriyama H, Kishida K, Hotta K, Nagaretani H, Maeda N, Matsuda M, Kihara S, Nakamura T, Nishigori H, Tomura H, Moore DD, Takeda J, Funahashi T, Matsuzawa Y.
|
| J Biol Chem. 277(2):1586-92. 2002
|
| 103 | PPARG
|
| Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility.
|
| Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, Wagner KU, Hennighausen L.
|
| J Biol Chem. 277(20):17830-5. 2002
|
| 104 | PPARG
|
| Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
|
| Wolfrum C, Borrmann CM, Borchers T, Spener F.
|
| Proc Natl Acad Sci U S A. 98(5):2323-8. 2001
|
| 105 | PPARG
|
| Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.
|
| Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J, Peters JM, Kaya G, Gonzalez FJ, Zakany J, Metzger D, Chambon P, Duboule D, Wahli W.
|
| J Cell Biol. 154(4):799-814. 2001
|
| 106 | PPARG
|
| Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.
|
| Kodera Y, Takeyama K, Murayama A, Suzawa M, Masuhiro Y, Kato S.
|
| J Biol Chem. 275(43):33201-4. 2000
|
| 107 | PPARG
|
| Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.
|
| Ikeda Y, Sugawara A, Taniyama Y, Uruno A, Igarashi K, Arima S, Ito S, Takeuchi K.
|
| J Biol Chem. 275(42):33142-50. 2000
|
| 108 | PPARG
|
| Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.
|
| Yang W, Rachez C, Freedman LP.
|
| Mol Cell Biol. 20(21):8008-17. 2000
|
| 109 | PPARG
|
| Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.
|
| Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, Xu HE.
|
| Mol Cell. 5(3):545-55. 2000
|
| 110 | PPARG
|
| Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
|
| Miles PD, Barak Y, He W, Evans RM, Olefsky JM.
|
| J Clin Invest. 105(3):287-92. 2000
|
| 111 | PPARG
|
| p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers.
|
| Monden T, Kishi M, Hosoya T, Satoh T, Wondisford FE, Hollenberg AN, Yamada M, Mori M.
|
| Mol Endocrinol. 13(10):1695-703. 1999
|
| 112 | PPARG
|
| Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma.
|
| Heinlein CA, Ting HJ, Yeh S, Chang C.
|
| J Biol Chem. 274(23):16147-52. 1999
|
| 113 | DIDAN, PPARG
|
| PPAR gamma is required for placental, cardiac, and adipose tissue development.
|
| Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM.
|
| Mol Cell. 4(4):585-95. 1999
|
| 114 | DIDAN, PPARG
|
| PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
|
| Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T, et al.
|
| Mol Cell. 4(4):597-609. 1999
|
| 115 | DIDAN, PPARG
|
| PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.
|
| Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM.
|
| Mol Cell. 4(4):611-7. 1999
|
| 116 | PPARG
|
| Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.
|
| Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK.
|
| J Biol Chem 272(8):5128-32.PMID: 9030579 1997
|
| 117 | PPARG
|
| Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2.
|
| Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE, Berger J.
|
| Biochem Biophys Res Commun. 224(2):431-7. 1996
|
| 118 | PPARG
|
| Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.
|
| Wan Y, Saghatelian A, Chong LW, Zhang CL, Cravatt BF, Evans RM.
|
| Genes Dev.
|